• Ramesh Kumar Mani

    Co-founder, PNI

    Ramesh has obtained his Ph.D. from the Memorial University of Newfoundland, Canada. He possesses over twelve years of academic and industrial experience in developing innovative polymeric and bioceramic composites for tissue engineering and implant coating applications.

  • Kishan Gorityala

    Co-founder, PNI

    Kishan holds Ph.D from Nanyang Technological University, Singapore. He has rich research experience in antibacterial drug discovery. He successfully developed novel new antibiotic molecules, which overcome the resistance against Gram-negative bacteria.

  • Prof. George Zhanel

    Professor: Dept. of Medical Microbiology/Infectious Diseases, Max Rady College of Medicine, University of Manitoba (1987 –present) and

    Coordinator: Antimicrobial Resistance Program, Departments of Medicine and Microbiology, Health Sciences Centre and

    Director: Canadian Antimicrobial Resistance Alliance (CARA), Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, CANADA

    Dr. Zhanel received his Ph.D. in the Department of Medical Microbiology/Infectious Diseases at the Faculty of Medicine, University of Manitoba and a Doctor of Clinical Pharmacology at the University of Minnesota. He is presently Professor in the Department of Medical Microbiology/Infectious Diseases, College of Medicine; Course Leader, Infectious Diseases Teaching, College of Medicine, University of Manitoba; Coordinator of Antibiotic Resistance in the Departments of Me

    Read more

  • Charles “Chuck” Love

    Charles “Chuck” Love is the founder and CEO of Venture Sciences Group (VSG). Prior to VSG, Chuck held strategic executive roles for companies pursing cutting-edge medical technologies including the Medtronic CoreValve transcatheter heart valve, Circulite Synergy ventricular assist system, and Endologix Nellix AAA graft. He holds seminal patents in the field of cardiac and vascular surgery. In addition to his employment history, Chuck has been an active investor, advisor and board member to a number of exiting med-tech start-ups including Loma vista Medical and LimFlow. He brings over three decades of experience to his companies offering a unique combination technical and clinical skills. Chuck studied mechanical engineering at Gonzaga University, holds a BA in Biology from Westmont College, and completed an executive business program through Stanford University.

  • Andrew Smith

    Dr. Andrew Smith is a Family/ER physician and Associate Professor (Memorial University) with over 10 years clinical experience. Prior to medicine, Andrew completed a master’s degree in electrical engineering and currently holds a cross-appointment to the Faculty of Engineering and Applied Sciences. Andrew is currently working with major organizations within the province to develop a medical technology sector in Newfoundland and Labrador and within Memorial University to develop formal biomedical engineering opportunities for both undergraduate and graduate students.

  • Carlos Bazan

    Carlos Bazan, Assistant Professor of Civil Engineering & Engineering Chair in Entrepreneurship, Memorial University.  Dr. Bazan has extensive experience and expertise in business, finance and management.  Dr. Bazan has been on the board of directors of several companies and institutions. He has worked as chief financial officer, finance manager, program manager and project manager for several organizations.  Dr. Bazan has engineered complex merger & acquisition deals, graduated from a technology business incubator and consulted for several start-up companies in the incubator, and worked for an investment bank to help identify new business opportunities among Latino entrepreneurs.

  • Vijay Chintamaneni

    For over 25 years, Mr. Chintamaneni has been a serial entrepreneur and a senior leader in manufacturing, marketing & advertising, publishing and education sectors. Mr. Chintamaneni has vast experience of working at a senior management level in North America, Europe, Middle East and Asia. His latest venture is aimed at consolidating mid-market for-profit vocational colleges in Canada with a potential market cap of $100 million over 10 years. In the past Mr. Chintamaneni successfully raised equity in Middle East and Asia and profitably exited these ventures.

  • Frank Schweizer

    Frank Schweizer is a Professor of Chemistry in the Departments of Chemistry and Medical Microbiology/Infectious Diseases at the University of Manitoba. His research focuses on preclinical drug discovery and development. He has co-authored more than 100 publications in peer-reviewed journals and holds over 10 patents.

  • Ayush Kumar

    Ayush Kumar is an Associate Professor in the Department of Microbiology. His research interests include studying the mechanisms of antibiotic resistance in Gram-negative bacteria such as Acinetobacter baumannii and Pseudomonas aeruginosa. His laboratory also studies the molecular mechanisms involved in cross-resistance between antibiotics and biocides.